MYH15
Myosin-15
Also known as: KIAA1000, MYH15_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y2K3
- Gene
- MYH15
- Ensembl
- ENSG00000144821
- Chromosome
- 3
- Canonical length
- 1926 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles,Cytosol
OverviewNCBI Gene
Predicted to enable actin filament binding activity and microfilament motor activity. Predicted to be involved in extraocular skeletal muscle development. Located in cytosol and intracellular membrane-bounded organelle. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
1926 residues, UniProt reviewed canonical sequence.
>Q9Y2K3|MYH15
1 MDLSDLGEAA AFLRRSEAEL LLLQATALDG KKKCWIPDGE NAYIEAEVKG SEDDGTVIVE
61 TADGESLSIK EDKIQQMNPP EFEMIEDMAM LTHLNEASVL HTLKRRYGQW MIYTYSGLFC
121 VTINPYKWLP VYQKEVMAAY KGKRRSEAPP HIFAVANNAF QDMLHNRENQ SILFTGESGA
181 GKTVNSKHII QYFATIAAMI ESRKKQGALE DQIMQANTIL EAFGNAKTLR NDNSSRFGKF
241 IRMHFGARGM LSSVDIDIYL LEKSRVIFQQ AGERNYHIFY QILSGQKELH DLLLVSANPS
301 DFHFCSCGAV TVESLDDAEE LLATEQAMDI LGFLPDEKYG CYKLTGAIMH FGNMKFKQKP
361 REEQLEADGT ENADKAAFLM GINSSELVKC LIHPRIKVGN EYVTRGQTIE QVTCAVGALS
421 KSMYERMFKW LVARINRALD AKLSRQFFIG ILDITGFEIL EYNSLEQLCI NFTNEKLQQF
481 FNWHMFVLEQ EEYKKESIEW VSIGFGLDLQ ACIDLIEKPM GILSILEEEC MFPKATDLTF
541 KTKLFDNHFG KSVHLQKPKP DKKKFEAHFE LVHYAGVVPY NISGWLEKNK DLLNETVVAV
601 FQKSSNRLLA SLFENYMSTD SAIPFGEKKR KKGASFQTVA SLHKENLNKL MTNLKSTAPH
661 FVRCINPNVN KIPGILDPYL VLQQLRCNGV LEGTRICREG FPNRLQYADF KQRYCILNPR
721 TFPKSKFVSS RKAAEELLGS LEIDHTQYRF GITKVFFKAG FLGQLEAIRD ERLSKVFTLF
781 QARAQGKLMR IKFQKILEER DALILIQWNI RAFMAVKNWP WMRLFFKIKP LVKSSEVGEE
841 VAGLKEECAQ LQKALEKSEF QREELKAKQV SLTQEKNDLI LQLQAEQETL ANVEEQCEWL
901 IKSKIQLEAR VKELSERVEE EEEINSELTA RGRKLEDECF ELKKEIDDLE TMLVKSEKEK
961 RTTEHKVKNL TEEVEFLNED ISKLNRAAKV VQEAHQQTLD DLHMEEEKLS SLSKANLKLE
1021 QQVDELEGAL EQERKARMNC ERELHKLEGN LKLNRESMEN LESSQRHLAE ELRKKELELS
1081 QMNSKVENEK GLVAQLQKTV KELQTQIKDL KEKLEAERTT RAKMERERAD LTQDLADLNE
1141 RLEEVGGSSL AQLEITKKQE TKFQKLHRDM EEATLHFETT SASLKKRHAD SLAELEGQVE
1201 NLQQVKQKLE KDKSDLQLEV DDLLTRVEQM TRAKANAEKL CTLYEERLHE ATAKLDKVTQ
1261 LANDLAAQKT KLWSESGEFL RRLEEKEALI NQLSREKSNF TRQIEDLRGQ LEKETKSQSA
1321 LAHALQKAQR DCDLLREQYE EEQEVKAELH RTLSKVNAEM VQWRMKYENN VIQRTEDLED
1381 AKKELAIRLQ EAAEAMGVAN ARNASLERAR HQLQLELGDA LSDLGKVRSA AARLDQKQLQ
1441 SGKALADWKQ KHEESQALLD ASQKEVQALS TELLKLKNTY EESIVGQETL RRENKNLQEE
1501 ISNLTNQVRE GTKNLTEMEK VKKLIEEEKT EVQVTLEETE GALERNESKI LHFQLELLEA
1561 KAELERKLSE KDEEIENFRR KQQCTIDSLQ SSLDSEAKSR IEVTRLKKKM EEDLNEMELQ
1621 LSCANRQVSE ATKSLGQLQI QIKDLQMQLD DSTQLNSDLK EQVAVAERRN SLLQSELEDL
1681 RSLQEQTERG RRLSEEELLE ATERINLFYT QNTSLLSQKK KLEADVARMQ KEAEEVVQEC
1741 QNAEEKAKKA AIEAANLSEE LKKKQDTIAH LERTRENMEQ TITDLQKRLA EAEQMALMGS
1801 RKQIQKLESR VRELEGELEG EIRRSAEAQR GARRLERCIK ELTYQAEEDK KNLSRMQTQM
1861 DKLQLKVQNY KQQVEVAETQ ANQYLSKYKK QQHELNEVKE RAEVAESQVN KLKIKAREFG
1921 KKVQEELocalizationUniProt · AlphaFold · HPA
Whether an antibody against MYH15 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 3 nTPM
Expression across tissuesHPA
Tissue
- retina: 3 nTPM
- tongue: 1.9 nTPM
- cerebral cortex: 1.2 nTPM
- small intestine: 0.6 nTPM
- colon: 0.4 nTPM
- duodenum: 0.4 nTPM
Single-cell type
- adrenal medulla cells: 43 nCPM
- bergmann glia: 38 nCPM
- astrocytes: 27 nCPM
- müller glia: 19 nCPM
- cone photoreceptor cells: 17 nCPM
- rod photoreceptor cells: 15 nCPM
Immune cell
- naive B-cell: 0.3 nTPM
- plasmacytoid DC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- basal ganglia: 3.8 nTPM
- medulla oblongata: 3.4 nTPM
- hypothalamus: 3.3 nTPM
- thalamus: 3.2 nTPM
- white matter: 3 nTPM
- amygdala: 2.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MYH15.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 363 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.06
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.1
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MYH15 as an antibody target. Whether an autoantibody or antibody against MYH15 could matter depends on whether native MYH15 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MYH15 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MYH15 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...